Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Novartis
Mayo Clinic
Italfarmaco
Incyte Corporation
AOP Orphan Pharmaceuticals AG
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Traws Pharma, Inc.
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Asan Medical Center
S*BIO
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center